Introduction

Tickets

Public Pricelist

Oligovax SAS

Operator of a biopharmaceutical company intended to provide therapies for cancer. The company develops drug substances consisting of synthetic oligonucleotides (ODNs) containing cytosine-guanine dinucleotide (CpG) motifs that have optimized immunostimulating properties, helping healthcare practitioners to cure patients suffering from cancer.

Oligovax SAS

Gentaur Group

9 Rue Lagrange, 75005 Paris, France.
+33 1 43 25 01 50
info@oligovax.com

CRISPR presentation by Gentaur at KULeuven

Introduction